MedPath

Enteral Nutrition After Pancreaticoduodenectomy

Not Applicable
Completed
Conditions
Cancer of Duodenum
Cancer of Pancreas
Cholangiocarcinoma
Ampulla of Vater Cancer
Interventions
Other: Saline
Other: Early enteral nutrition
Device: nasojejunal tube insertion
Other: Oral intake
Registration Number
NCT03150615
Lead Sponsor
Nanjing Medical University
Brief Summary

Pancreaticoduodenectomy (PD) is the treatment of choice for resectable periampullary cancer. PD is still associated with a relatively a high incidence of delayed gastric emptying. And, there are no acknowledged strategies to avoid DGE. Several feeding strategies have been investigated to cope with this problem. However, there is still no consensus concerning the best nutrition support method after pancreaticoduodenectomy. The purpose of this study is to determine the effect of nutrition support methods on DGE after pancreaticoduodenectomy: early enteral nutrition or total parenteral nutrition.

Patients undergoing pancreatoduodenectomy will be randomized to receive early enteral nutrition (EN group), or Saline administration (Saline group), or oral intake only (Natural control). The EN group will receive standard enteral diet administered through a nasojejunal tube. Enteral nutrition will be started on the 1st postoperative day and increased daily by 20-40 ml up to the estimated level. The Saline group will receive saline administered through a nasojejunal tube beginning from the 1st postoperative day. Oral intake will not be restricted in all three group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients underwent selective pancreaticoduodenectomy Patients ≥18 years old and ≤80 years old Having given written informed consent

Exclusion Criteria

Previous gastric resection or intestinal reconstruction Preoperative complete parenteral or enteral feeding ASA score ≥4 Pregnant women Severe malnutrition Patient who cannot give written informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Early enteral nutritionOral intakeNasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Saline Groupnasojejunal tube insertionNasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Saline GroupSalineNasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Early enteral nutritionnasojejunal tube insertionNasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
ERAS Groupnasojejunal tube insertionNasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
ERAS GroupOral intakeNasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Early enteral nutritionEarly enteral nutritionNasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Primary Outcome Measures
NameTimeMethod
Incident rate of delayed gastric emptying30 days

DGE represents the inability to return to a standard diet by the end of the first postoperative week and includes prolonged nasogastric intubation of the patient. Three different grades (A,B,and C) were defined based on the impact on the clinical course and on postoperative management by ISGPS.

Secondary Outcome Measures
NameTimeMethod
Pancreatic fistulas30 days

evaluation of the occurrence of pancreatic fistulas, grade B and C, in both groups of patients

Maximum Plasma Concentration fasting plasma GLP-1 levelPreoperative day 1, Postoperative day 1, Postoperative day 4, Postoperative day 7

Fasting plasma concentration GLP-1 level was monitored

Infectious complications30 days
Postoperative mortality rate30 days
Overall morbidity rate30 days
Rehospitalization rate60 days
Postoperative hospital stay length60 days
Evaluation of the severity of the complications30 days

according to classification of Dindo-Clavien

Hemorrhagic complications30 days

evaluation of the occurrence of hemorrhagic complications, grade B and C, in both groups of patients

Trial Locations

Locations (1)

The first affiliated hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath